ID   TPC1_HUMAN              Reviewed;         816 AA.
AC   Q9ULQ1; A7E258; Q86XS9; Q8NC20;
DT   06-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 3.
DT   28-JUN-2023, entry version 167.
DE   RecName: Full=Two pore channel protein 1 {ECO:0000305};
DE   AltName: Full=Two pore calcium channel protein 1;
DE   AltName: Full=Voltage-dependent calcium channel protein TPC1;
GN   Name=TPCN1 {ECO:0000312|HGNC:HGNC:18182};
GN   Synonyms=KIAA1169, TPC1 {ECO:0000303|PubMed:24776928,
GN   ECO:0000303|PubMed:25722412};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=19387438; DOI=10.1038/nature08030;
RA   Calcraft P.J., Ruas M., Pan Z., Cheng X., Arredouani A., Hao X., Tang J.,
RA   Rietdorf K., Teboul L., Chuang K.T., Lin P., Xiao R., Wang C., Zhu Y.,
RA   Lin Y., Wyatt C.N., Parrington J., Ma J., Evans A.M., Galione A., Zhu M.X.;
RT   "NAADP mobilizes calcium from acidic organelles through two-pore
RT   channels.";
RL   Nature 459:596-600(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=10574461; DOI=10.1093/dnares/6.5.329;
RA   Hirosawa M., Nagase T., Ishikawa K., Kikuno R., Nomura N., Ohara O.;
RT   "Characterization of cDNA clones selected by the GeneMark analysis from
RT   size-fractionated cDNA libraries from human brain.";
RL   DNA Res. 6:329-336(1999).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, MUTAGENESIS OF LEU-273, AND SUBCELLULAR LOCATION.
RX   PubMed=19620632; DOI=10.1083/jcb.200904073;
RA   Brailoiu E., Churamani D., Cai X., Schrlau M.G., Brailoiu G.C., Gao X.,
RA   Hooper R., Boulware M.J., Dun N.J., Marchant J.S., Patel S.;
RT   "Essential requirement for two-pore channel 1 in NAADP-mediated calcium
RT   signaling.";
RL   J. Cell Biol. 186:201-209(2009).
RN   [8]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF 740-LEU-LEU-741.
RX   PubMed=20880839; DOI=10.1074/jbc.m110.162073;
RA   Brailoiu E., Rahman T., Churamani D., Prole D.L., Brailoiu G.C., Hooper R.,
RA   Taylor C.W., Patel S.;
RT   "An NAADP-gated two-pore channel targeted to the plasma membrane uncouples
RT   triggering from amplifying Ca2+ signals.";
RL   J. Biol. Chem. 285:38511-38516(2010).
RN   [9]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23063126; DOI=10.1016/j.cell.2012.08.036;
RA   Wang X., Zhang X., Dong X.P., Samie M., Li X., Cheng X., Goschka A.,
RA   Shen D., Zhou Y., Harlow J., Zhu M.X., Clapham D.E., Ren D., Xu H.;
RT   "TPC proteins are phosphoinositide- activated sodium-selective ion channels
RT   in endosomes and lysosomes.";
RL   Cell 151:372-383(2012).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, AND INTERACTION WITH MTOR.
RX   PubMed=23394946; DOI=10.1016/j.cell.2013.01.023;
RA   Cang C., Zhou Y., Navarro B., Seo Y.J., Aranda K., Shi L.,
RA   Battaglia-Hsu S., Nissim I., Clapham D.E., Ren D.;
RT   "mTOR regulates lysosomal ATP-sensitive two-pore Na(+) channels to adapt to
RT   metabolic state.";
RL   Cell 152:778-790(2013).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF 219-ARG--ARG-223 AND ARG-539,
RP   AND DOMAIN.
RX   PubMed=24776928; DOI=10.1038/nchembio.1522;
RA   Cang C., Bekele B., Ren D.;
RT   "The voltage-gated sodium channel TPC1 confers endolysosomal
RT   excitability.";
RL   Nat. Chem. Biol. 10:463-469(2014).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   FUNCTION (MICROBIAL INFECTION), ACTIVITY REGULATION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=25722412; DOI=10.1126/science.1258758;
RA   Sakurai Y., Kolokoltsov A.A., Chen C.C., Tidwell M.W., Bauta W.E.,
RA   Klugbauer N., Grimm C., Wahl-Schott C., Biel M., Davey R.A.;
RT   "Ebola virus. Two-pore channels control Ebola virus host cell entry and are
RT   drug targets for disease treatment.";
RL   Science 347:995-998(2015).
RN   [14]
RP   REVIEW OF FUNCTION.
RX   PubMed=32679067; DOI=10.1016/j.tips.2020.06.002;
RA   Jin X., Zhang Y., Alharbi A., Hanbashi A., Alhoshani A., Parrington J.;
RT   "Targeting Two-Pore Channels: Current Progress and Future Challenges.";
RL   Trends Pharmacol. Sci. 41:582-594(2020).
RN   [15]
RP   INTERACTION WITH JPT2.
RX   PubMed=33758061; DOI=10.1126/scisignal.abd5605;
RA   Gunaratne G.S., Brailoiu E., He S., Unterwald E.M., Patel S., Slama J.T.,
RA   Walseth T.F., Marchant J.S.;
RT   "Essential requirement for JPT2 in NAADP-evoked Ca2+ signaling.";
RL   Sci. Signal. 14:0-0(2021).
RN   [16]
RP   SUBUNIT.
RX   PubMed=34362892; DOI=10.1038/s41467-021-24735-z;
RA   Zhang J., Guan X., Shah K., Yan J.;
RT   "Lsm12 is an NAADP receptor and a two-pore channel regulatory protein
RT   required for calcium mobilization from acidic organelles.";
RL   Nat. Commun. 12:4739-4739(2021).
CC   -!- FUNCTION: Intracellular channel initially characterized as a non-
CC       selective Ca(2+)-permeable channel activated by NAADP (nicotinic acid
CC       adenine dinucleotide phosphate), it is also a voltage-gated highly-
CC       selective Na(+) channel activated directly by PI(3,5)P2
CC       (phosphatidylinositol 3,5-bisphosphate) that senses pH changes and
CC       confers electrical excitability to organelles (PubMed:19620632,
CC       PubMed:23063126, PubMed:24776928, PubMed:23394946). Localizes to the
CC       early and recycling endosomes membranes where it plays a role in the
CC       uptake and processing of proteins and regulates organellar membrane
CC       excitability, membrane trafficking and pH homeostasis (PubMed:23394946)
CC       (Probable). Ion selectivity is not fixed but rather agonist-dependent
CC       and under defined ionic conditions, can be readily activated by both
CC       NAADP and PI(3,5)P2 (Probable). Required for mTOR-dependent nutrient
CC       sensing (PubMed:23394946) (Probable). {ECO:0000269|PubMed:19620632,
CC       ECO:0000269|PubMed:23063126, ECO:0000269|PubMed:23394946,
CC       ECO:0000269|PubMed:24776928, ECO:0000305|PubMed:32679067}.
CC   -!- FUNCTION: (Microbial infection) During Ebola virus (EBOV) infection,
CC       controls the movement of endosomes containing virus particles and is
CC       required by EBOV to escape from the endosomal network into the cell
CC       cytoplasm. {ECO:0000269|PubMed:25722412}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Na(+)(in) = Na(+)(out); Xref=Rhea:RHEA:34963,
CC         ChEBI:CHEBI:29101; Evidence={ECO:0000269|PubMed:23394946,
CC         ECO:0000269|PubMed:24776928};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:34965;
CC         Evidence={ECO:0000269|PubMed:23394946, ECO:0000269|PubMed:24776928};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Ca(2+)(in) = Ca(2+)(out); Xref=Rhea:RHEA:29671,
CC         ChEBI:CHEBI:29108; Evidence={ECO:0000269|PubMed:19387438};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:29673;
CC         Evidence={ECO:0000269|PubMed:19387438};
CC   -!- ACTIVITY REGULATION: Na(+) current is inhibited by ATP in a MTORC-
CC       dependent manner. ATP sensitivity is independent of PI(3,5)P2
CC       (PubMed:23394946). Probably regulated by Mg(2+) ions, cytosolic Mg(2+)
CC       selectively inhibits outward current while lysosomal Mg(2+) modestly
CC       inhibits both the outward and inward currents. In the absence of
CC       Mg(2+), NAADP readily activates TPCN2, with properties similar to
CC       PI(3,5)P2 (By similarity). Both current elicited by PI(3,5)P2 as well
CC       as NAADP are inhibited by tetrandrine. {ECO:0000250|UniProtKB:Q8NHX9,
CC       ECO:0000269|PubMed:23394946, ECO:0000269|PubMed:25722412}.
CC   -!- SUBUNIT: Dimer. Interacts with MTOR; the interaction is required for
CC       TPCN1 ATP sensitivity (PubMed:23394946). Interacts with STX7, STX8 and
CC       STX12 (By similarity). Interacts with JPT2 (PubMed:33758061). Found in
CC       a complex with LSM12, TPCN1 and TPCN2 (PubMed:34362892).
CC       {ECO:0000250|UniProtKB:Q9EQJ0, ECO:0000269|PubMed:23394946,
CC       ECO:0000269|PubMed:33758061, ECO:0000269|PubMed:34362892, ECO:0000305}.
CC   -!- INTERACTION:
CC       Q9ULQ1; O00165: HAX1; NbExp=2; IntAct=EBI-5239895, EBI-357001;
CC       Q9ULQ1; Q9ULQ1: TPCN1; NbExp=3; IntAct=EBI-5239895, EBI-5239895;
CC       Q9ULQ1; Q8NHX9: TPCN2; NbExp=9; IntAct=EBI-5239895, EBI-5239949;
CC   -!- SUBCELLULAR LOCATION: Lysosome membrane {ECO:0000269|PubMed:19620632,
CC       ECO:0000269|PubMed:23063126, ECO:0000269|PubMed:25722412}; Multi-pass
CC       membrane protein {ECO:0000269|PubMed:19620632}. Endosome membrane
CC       {ECO:0000269|PubMed:19620632, ECO:0000269|PubMed:20880839,
CC       ECO:0000269|PubMed:23063126, ECO:0000269|PubMed:25722412}; Multi-pass
CC       membrane protein {ECO:0000269|PubMed:19620632}. Early endosome membrane
CC       {ECO:0000250|UniProtKB:Q9EQJ0}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9EQJ0}. Recycling endosome membrane
CC       {ECO:0000250|UniProtKB:Q9EQJ0}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9EQJ0}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9ULQ1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9ULQ1-2; Sequence=VSP_023003, VSP_023004, VSP_023005;
CC       Name=3;
CC         IsoId=Q9ULQ1-3; Sequence=VSP_041346;
CC   -!- TISSUE SPECIFICITY: Highest expression found in the heart and kidney,
CC       and lowest expression found in the spleen.
CC       {ECO:0000269|PubMed:10574461}.
CC   -!- DOMAIN: Each of the two internal repeats contains five hydrophobic
CC       transmembrane segments (S1, S2, S3, S5, S6) and one positively charged
CC       transmembrane segment (S4). S4 segments represent the voltage-sensor
CC       and are characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000269|PubMed:24776928}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:Q9EQJ0}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit
CC       (TC 1.A.1.11) family. Two pore calcium channel subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AK057414; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAA86483.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY083666; AAM01199.1; -; mRNA.
DR   EMBL; AB032995; BAA86483.2; ALT_INIT; mRNA.
DR   EMBL; AK057414; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK075071; BAC11385.1; -; mRNA.
DR   EMBL; AC010178; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC089999; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC127004; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC136795; AAI36796.1; -; mRNA.
DR   EMBL; BC136796; AAI36797.1; -; mRNA.
DR   EMBL; BC150203; AAI50204.1; -; mRNA.
DR   EMBL; BC152423; AAI52424.1; -; mRNA.
DR   CCDS; CCDS31908.1; -. [Q9ULQ1-1]
DR   CCDS; CCDS44985.1; -. [Q9ULQ1-3]
DR   RefSeq; NP_001137291.1; NM_001143819.2. [Q9ULQ1-3]
DR   RefSeq; NP_001288143.1; NM_001301214.1.
DR   RefSeq; NP_060371.2; NM_017901.5. [Q9ULQ1-1]
DR   RefSeq; XP_011536792.1; XM_011538490.2.
DR   RefSeq; XP_011536794.1; XM_011538492.2. [Q9ULQ1-1]
DR   AlphaFoldDB; Q9ULQ1; -.
DR   SMR; Q9ULQ1; -.
DR   BioGRID; 119760; 33.
DR   IntAct; Q9ULQ1; 9.
DR   MINT; Q9ULQ1; -.
DR   STRING; 9606.ENSP00000448083; -.
DR   DrugCentral; Q9ULQ1; -.
DR   GuidetoPHARMACOLOGY; 392; -.
DR   TCDB; 1.A.1.11.25; the voltage-gated ion channel (vic) superfamily.
DR   GlyCosmos; Q9ULQ1; 3 sites, No reported glycans.
DR   GlyGen; Q9ULQ1; 3 sites.
DR   iPTMnet; Q9ULQ1; -.
DR   PhosphoSitePlus; Q9ULQ1; -.
DR   SwissPalm; Q9ULQ1; -.
DR   BioMuta; TPCN1; -.
DR   DMDM; 125991219; -.
DR   EPD; Q9ULQ1; -.
DR   jPOST; Q9ULQ1; -.
DR   MassIVE; Q9ULQ1; -.
DR   MaxQB; Q9ULQ1; -.
DR   PaxDb; Q9ULQ1; -.
DR   PeptideAtlas; Q9ULQ1; -.
DR   ProteomicsDB; 85094; -. [Q9ULQ1-1]
DR   ProteomicsDB; 85095; -. [Q9ULQ1-2]
DR   ProteomicsDB; 85096; -. [Q9ULQ1-3]
DR   Antibodypedia; 31242; 86 antibodies from 19 providers.
DR   DNASU; 53373; -.
DR   Ensembl; ENST00000335509.11; ENSP00000335300.6; ENSG00000186815.13. [Q9ULQ1-1]
DR   Ensembl; ENST00000541517.5; ENSP00000438125.1; ENSG00000186815.13. [Q9ULQ1-3]
DR   Ensembl; ENST00000550785.5; ENSP00000448083.1; ENSG00000186815.13. [Q9ULQ1-3]
DR   GeneID; 53373; -.
DR   KEGG; hsa:53373; -.
DR   MANE-Select; ENST00000335509.11; ENSP00000335300.6; NM_017901.6; NP_060371.2.
DR   UCSC; uc001tuw.4; human. [Q9ULQ1-1]
DR   AGR; HGNC:18182; -.
DR   CTD; 53373; -.
DR   DisGeNET; 53373; -.
DR   GeneCards; TPCN1; -.
DR   HGNC; HGNC:18182; TPCN1.
DR   HPA; ENSG00000186815; Low tissue specificity.
DR   MIM; 609666; gene.
DR   neXtProt; NX_Q9ULQ1; -.
DR   OpenTargets; ENSG00000186815; -.
DR   PharmGKB; PA134922711; -.
DR   VEuPathDB; HostDB:ENSG00000186815; -.
DR   eggNOG; KOG2301; Eukaryota.
DR   GeneTree; ENSGT00940000158958; -.
DR   InParanoid; Q9ULQ1; -.
DR   OrthoDB; 5403296at2759; -.
DR   PhylomeDB; Q9ULQ1; -.
DR   TreeFam; TF328550; -.
DR   PathwayCommons; Q9ULQ1; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   SignaLink; Q9ULQ1; -.
DR   BioGRID-ORCS; 53373; 14 hits in 1160 CRISPR screens.
DR   ChiTaRS; TPCN1; human.
DR   GeneWiki; TPCN1; -.
DR   GenomeRNAi; 53373; -.
DR   Pharos; Q9ULQ1; Tchem.
DR   PRO; PR:Q9ULQ1; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q9ULQ1; protein.
DR   Bgee; ENSG00000186815; Expressed in right hemisphere of cerebellum and 200 other tissues.
DR   ExpressionAtlas; Q9ULQ1; baseline and differential.
DR   Genevisible; Q9ULQ1; HS.
DR   GO; GO:0031901; C:early endosome membrane; ISS:UniProtKB.
DR   GO; GO:0036019; C:endolysosome; IDA:UniProtKB.
DR   GO; GO:0005768; C:endosome; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0010008; C:endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0005764; C:lysosome; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0055038; C:recycling endosome membrane; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0097682; F:intracellular phosphatidylinositol-3,5-bisphosphate-sensitive monatomic cation channel activity; IDA:UniProtKB.
DR   GO; GO:0015280; F:ligand-gated sodium channel activity; IDA:UniProtKB.
DR   GO; GO:0072345; F:NAADP-sensitive calcium-release channel activity; IDA:UniProtKB.
DR   GO; GO:0080025; F:phosphatidylinositol-3,5-bisphosphate binding; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0019905; F:syntaxin binding; IEA:Ensembl.
DR   GO; GO:0005244; F:voltage-gated monoatomic ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; IDA:UniProtKB.
DR   GO; GO:0075509; P:endocytosis involved in viral entry into host cell; IMP:UniProtKB.
DR   GO; GO:0034220; P:monoatomic ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0010508; P:positive regulation of autophagy; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0034765; P:regulation of monoatomic ion transmembrane transport; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.287.70; -; 2.
DR   Gene3D; 1.20.120.350; Voltage-gated potassium channels. Chain C; 1.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR028801; TPC1_animal.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   PANTHER; PTHR46474; TWO PORE CALCIUM CHANNEL PROTEIN 1; 1.
DR   PANTHER; PTHR46474:SF1; TWO PORE CALCIUM CHANNEL PROTEIN 1; 1.
DR   Pfam; PF00520; Ion_trans; 2.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Coiled coil; Endosome; Glycoprotein; Ion channel; Ion transport; Lysosome;
KW   Membrane; Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   CHAIN           1..816
FT                   /note="Two pore channel protein 1"
FT                   /id="PRO_0000276853"
FT   TOPO_DOM        1..112
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        113..133
FT                   /note="Helical; Name=S1 of repeat I"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        134
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        135..155
FT                   /note="Helical; Name=S2 of repeat I"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        156..177
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        178..198
FT                   /note="Helical; Name=S3 of repeat I"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        199..200
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        201..220
FT                   /note="Helical; Name=S4 of repeat I"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        221..234
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        235..255
FT                   /note="Helical; Name=S5 of repeat I"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        256..262
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        263..286
FT                   /note="Helical; Pore-forming"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        287..294
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        295..315
FT                   /note="Helical; Name=S6 of repeat I"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        316..444
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        445..465
FT                   /note="Helical; Name=S1 of repeat II"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        466..479
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        480..500
FT                   /note="Helical; Name=S2 of repeat II"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        501..503
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        504..526
FT                   /note="Helical; Name=S3 of repeat II"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        527..534
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        535..549
FT                   /note="Helical; Name=S4 of repeat II"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        550..573
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        574..594
FT                   /note="Helical; Name=S5 of repeat II"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        595..629
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        630..653
FT                   /note="Helical; Pore-forming"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        654..670
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        671..691
FT                   /note="Helical; Name=S6 of repeat II"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        692..816
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          17..64
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          782..816
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          769..796
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        41..64
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        791..816
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        599
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        611
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        616
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..366
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_023003"
FT   VAR_SEQ         1
FT                   /note="M -> MESCYIAQAGLELLGSSSSPTLTSQSAEITEDASNGGVSEQHPWPSG
FT                   FERELKPETISSPGYHILRATGEENM (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_041346"
FT   VAR_SEQ         569..618
FT                   /note="SLGLTLLIFYYSFAIVGMEFFCGIVFPNCCNTSTVADAYRWRNHTVGNRT
FT                   -> RYCQPPPWPAGPGAVWQCPVGAGAEWQSGERSSTKDCNRGPDGAPRSLES (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_023004"
FT   VAR_SEQ         619..816
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_023005"
FT   MUTAGEN         219..223
FT                   /note="RRNLR->QQNLQ: Loss of voltage sensitivity."
FT                   /evidence="ECO:0000269|PubMed:24776928"
FT   MUTAGEN         273
FT                   /note="L->P: Loss of NAADP-mediated cytoplasmic calcium
FT                   release."
FT                   /evidence="ECO:0000269|PubMed:19620632"
FT   MUTAGEN         539
FT                   /note="R->I: Loss of voltage sensitivity."
FT                   /evidence="ECO:0000269|PubMed:24776928"
FT   MUTAGEN         740..741
FT                   /note="LL->AA: No effect on subcellular location."
FT                   /evidence="ECO:0000269|PubMed:20880839"
FT   CONFLICT        621
FT                   /note="E -> G (in Ref. 4; AK057414)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   816 AA;  94147 MW;  D6D26BFAF33E1463 CRC64;
     MAVSLDDDVP LILTLDEGGS APLAPSNGLG QEELPSKNGG SYAIHDSQAP SLSSGGESSP
     SSPAHNWEMN YQEAAIYLQE GENNDKFFTH PKDAKALAAY LFAHNHLFYL MELATALLLL
     LLSLCEAPAV PALRLGIYVH ATLELFALMV VVFELCMKLR WLGLHTFIRH KRTMVKTSVL
     VVQFVEAIVV LVRQMSHVRV TRALRCIFLV DCRYCGGVRR NLRQIFQSLP PFMDILLLLL
     FFMIIFAILG FYLFSPNPSD PYFSTLENSI VSLFVLLTTA NFPDVMMPSY SRNPWSCVFF
     IVYLSIELYF IMNLLLAVVF DTFNDIEKRK FKSLLLHKRT AIQHAYRLLI SQRRPAGISY
     RQFEGLMRFY KPRMSARERY LTFKALNQNN TPLLSLKDFY DIYEVAALKW KAKKNREHWF
     DELPRTALLI FKGINILVKS KAFQYFMYLV VAVNGVWILV ETFMLKGGNF FSKHVPWSYL
     VFLTIYGVEL FLKVAGLGPV EYLSSGWNLF DFSVTVFAFL GLLALALNME PFYFIVVLRP
     LQLLRLFKLK ERYRNVLDTM FELLPRMASL GLTLLIFYYS FAIVGMEFFC GIVFPNCCNT
     STVADAYRWR NHTVGNRTVV EEGYYYLNNF DNILNSFVTL FELTVVNNWY IIMEGVTSQT
     SHWSRLYFMT FYIVTMVVMT IIVAFILEAF VFRMNYSRKN QDSEVDGGIT LEKEISKEEL
     VAVLELYREA RGASSDVTRL LETLSQMERY QQHSMVFLGR RSRTKSDLSL KMYQEEIQEW
     YEEHAREQEQ QRQLSSSAAP AAQQPPGSRQ RSQTVT
//
